Reducing Hereditary Cancer Act
119-HR-4752119th CongressIntroduced Jul 23, 2025Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Wasserman Schultz, Debbie [D-FL-25](D-FL-25)24 cosponsors
Summary
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Actions (4)
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 23, 2025House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 23, 2025House floor actions
Introduced in House
Jul 23, 2025Library of Congress
Introduced in House
Jul 23, 2025Library of Congress